Cetuximab Plus Platinum-Based Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Randomized, Double-Blind Safety Study Comparing Cetuximab Produced From Two Manufacturing Processes Using the EXTREME Study Regimen
BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2064-0
Full Text
Open PDFAbstract
Available in full text
Date
January 14, 2016
Authors
Publisher
Springer Science and Business Media LLC